Benjamin LONGO-MBENZA received his MD, PhD in  pathophysiology and MMed in Internal Medicine from the  Bukarest Medical Institute (Romania), MSc in Cardiology and  PhD in Cardiology at the Free University of Brussels (Belgium).  He is a former Fulbright Scholar and visiting Professor in Clinical  Pharmacology/Hypertension at the Institute of Lipid research,  Baylor College of medicine, Houston. He served for 30  years as chief of Cardiology, Executive Dean of the Faculty of  Medicine and Deputy Vice-Chancellor at the University of  Kinshasa. He is a member of 30  scientific societies, including: American Heart Association,  American Diabetes Association, and American College of  Cardiology, European Society of Cardiology and Pan-African  Society of Cardiology. He obtained a certificate in cardiovascular  Epidemiology (Netherlands), Ethics (NIH), Bioethics (Oklahoma  University) and Molecular genetics (Belgium, Italy). His original  research was focused on elucidating the pathophysiological  mechanisms of toxic myocarditis and immune-allergic  cardiomyopathies. From 1980s until present, most of his  research works are related to inflammatory states, oxidative  stress, molecular biology, genetics, biomarkers and  environmental impacts in Atherosclerosis, HIV/AIDS-related  cardiac lesions, deafness (discovery of genes) and co expression of genes in Pancreas. In addition to his role as  clinician, lecturer, academic leader mentor, WHO expert and  UN/Climate change Expert, he has been a very productive scientist. He has published over 300 papers. He is currently Research  Champion Professor at the Faculty of Health Sciences, Walter  Sisulu University, South Africa.